Showing 21 - 40 results of 46 for search '"epithelial ovarian cancer"', query time: 0.07s Refine Results
  1. 21
  2. 22
  3. 23

    Ultrasonic radiomics-based nomogram for preoperative prediction of residual tumor in advanced epithelial ovarian cancer: a multicenter retrospective study by Shanshan Li, Qiuping Ding, Lijuan Li, Yuwei Liu, Hanyu Zou, Yushuang Wang, Xiangyu Wang, Bingqing Deng, Qingxiu Ai

    Published 2025-02-01
    “…ObjectivesTo identify radiomic features extracted from ultrasound images and to develop and externally validate a comprehensive model that combines clinical data with ultrasound radiomics features to predict the residual tumor status in patients with advanced epithelial ovarian cancer (OC).MethodsThe study included 112 patients with advanced epithelial OC who underwent preoperative transvaginal ultrasound. …”
    Get full text
    Article
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30

    HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas by M. J. Rutten, F. Dijk, C. D. Savci-Heijink, M. R. Buist, G. G. Kenter, M. J. van de Vijver, E. S. Jordanova

    Published 2014-01-01
    “…Here, we evaluated the prognostic value of classical (A/B/C) and nonclassical (G/E) HLA expression in 169 high grade epithelial ovarian cancer samples and linked that to clinicopathological characteristics and survival. …”
    Get full text
    Article
  11. 31
  12. 32

    Ovarian Epithelial Cancer Stem Cells by Irena Conic, Irena Dimov, Desanka Tasic-Dimov, Biljana Djordjevic, Vladisav Stefanovic

    Published 2011-01-01
    “…The realization of epithelial ovarian cancer (EOC) as a CSC-related disease has the potential to change approaches in the treatment of this devastating disease dramatically. …”
    Get full text
    Article
  13. 33

    Retroperitoneal Extraovarian Fibrothecoma Mimicking a Malignant Epithelial Ovarian Carcinoma by Patrick Roberts, Sharon Nofech-Mozes, Natalie Coburn, Paul Hamilton, Lilian T. Gien

    Published 2012-01-01
    “…We report the third case of an extraovarian fibrothecoma and the first presenting similarly to a metastatic epithelial ovarian cancer. Clinical History. We describe a 62-year-old woman with history, physical examination, and imaging suggestive of metastatic ovarian cancer. …”
    Get full text
    Article
  14. 34

    Endometriosis-associated Ovarian Cancer, from Risk Factors to Survival Rate: A Systematic Review and Meta-Analysis by Elham Askary, Saeed Alborzi, Kefayat Chamanara, Alimohammad Keshtvarz Hesam Abadi

    Published 2025-01-01
    “…This meta-analysis aims to assess the prevalence and prognosis of endometriosis-associated ovarian cancer (EAOC) in various types of epithelial ovarian cancer (EOC), and compare risk factors with the non-EAOC group to improve disease management.Method: In this review, PubMed, Science Direct, Scopus, Google Scholar, and Cochrane databases were searched for "endometriosis" and "ovarian cancer risk factor" from 2010 to 2023. …”
    Get full text
    Article
  15. 35

    Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience by V. Zanagnolo, D. Rollo, T. Tomaselli, P. G. Rosenberg, L. Bocciolone, F. Landoni, G. Aletti, M. Peiretti, F. Sanguineti, A. Maggioni

    Published 2013-01-01
    “…The primary diagnosis was as follows: 6 cases of endometrial cancer, 31 epithelial ovarian cancer, 9 nonepithelial ovarian cancer, 4 tubal cancer, and 1 cervical cancer. …”
    Get full text
    Article
  16. 36

    Association between cytokines and progression-free survival in ovarian cancer following CRS/HIPEC treatment by Chao-Yu Chen, Ting-Yao Wang, Jing-Lan Liu, Yu-Che Ou, Li-Wen Lee, Chien-Hui Hung, Chuan-Pin Lee, Jrhau Lung

    Published 2025-01-01
    “…Abstract Background The benefit of cytoreduction with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for epithelial ovarian cancer (EOC) remains uncertain. This study investigated the relationship between serum cytokines, particularly monocyte chemoattractant protein-1 (MCP-1), a key inflammatory mediator, and recurrence risk in EOC patients undergoing CRS/HIPEC. …”
    Get full text
    Article
  17. 37

    Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study by Mercè Marzo-Castillejo, Josep M Borras, Carmen Vela-Vallespín, Paula Manchon‐Walsh, Luisa Aliste

    Published 2022-07-01
    “…Objective To assess the impact of prehospital factors (diagnostic pathways, first presentation to healthcare services, intervals, participation in primary care) on 1-year and 5-year survival in people with epithelial ovarian cancer (EOC).Design Retrospective quasi-population-based cohort study.Setting Catalan Integrated Public Healthcare System.Participants People with EOC who underwent surgery with a curative intent in public Catalan hospitals between 1 January 2013 and 31 December 2014.Outcome measures Data from primary and secondary care clinical histories and care processes in the 18 months leading up to confirmation (signs and symptoms at presentation, diagnosis pathways, referrals, diagnosis interval) of the EOC diagnosis (stage, histology type, treatment). …”
    Get full text
    Article
  18. 38

    A Rare Case of Metachronous Clear Cell Ovarian Carcinoma and Thyroid Carcinoma: Clinical and Pathological Insights by Ridwan S, Harsono AB, Suardi D, Kurniadi A, Mantilidewi KI, Hidayat YM

    Published 2025-01-01
    “…Pasteur 38, Bandung, West Java, 40161, Indonesia, Email kemala.i.mantilidewi@unpad.ac.idBackground: Clear cell ovarian carcinoma (CCOC) is a type of epithelial ovarian cancer, representing 5– 11% of ovarian cancers. …”
    Get full text
    Article
  19. 39

    Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer by Se Ik Kim, Hee Seung Kim, Tae Hun Kim, Dong Hoon Suh, Kidong Kim, Jae Hong No, Hyun Hoon Chung, Yong Beom Kim, Yong Sang Song

    Published 2014-01-01
    “…A total of 360 patients with stage III-IV epithelial ovarian cancer were enrolled and divided into three groups by body mass indexes (BMIs): underweight (BMI < 18.5 kg/m2); normal weight to overweight (18.5 kg/m2 BMI < 27.5 kg/m2); obesity (BMI ≥ 27.5 kg/m2). …”
    Get full text
    Article
  20. 40

    Transcriptome analysis reveals the anticancer effects of fenbendazole on ovarian cancer: an in vitro and in vivo study by Xin Wang, Wenda Tian, Ning Wang, Xiangqun Yang, Zhenyan Liu, Lvzhou Li, Taoyu Zhao, Chuanlin Wang, Hongping Zhang, Hongying Yang, Yue Jia

    Published 2024-12-01
    “…Here, we investigated the anticancer effects of fenbendazole (FBZ), a benzimidazole compound, on the regulation of apoptosis and mitotic catastrophe in A2780 and SKOV3 human epithelial ovarian cancer cells. Functional experiments, including Cell Counting Kit 8 (CCK-8), colony formation, and flow cytometry assays, were conducted to explore the effects of FBZ on the malignant biological behavior of A2780 and SKOV3 cells. …”
    Get full text
    Article